Remifentanil Hydrochloride Injection — FDA Drug Shortage

Current — Mylan Institutional, A Viatris Company

The FDA lists a drug shortage record for Remifentanil Hydrochloride Injection (injection) from Mylan Institutional, A Viatris Company with status Current. The shortage was first posted on Jun 28, 2022.

Shortage details

Status
Current
Company
Mylan Institutional, A Viatris Company
Package NDC
72078-034-01
Dosage Form
Injection
Presentation
Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01)
Initial Posting
Jun 28, 2022

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.